The Microbiome and Cancer Treatment

Dr. Aggarwal is currently a senior postdoctoral fellow at the MD Anderson Cancer Center, Texas, USA. She completed Ph.D. from AIIMS, New Delhi under supervision of Prof. S. N. Das. During PhD, wherein she successfully addressed various aspects of local immunopathology in oral squamous cell carcinoma (OSCC). She published dozens of articles and several book chapters. She is an editorial board member of several indexed reputed international journals. Garima Malik has completed her B. Pharmacy from Vaish Institute of Pharmaceutical Education and Research, Rohtak, and an M.Pharmacy from Chandigarh College of Pharmacy, Landran. She has more than 3 years of experience as an Assistant Professor in the Department of Pharmaceutics. Currently, she is working as an Assistant Professor at M.M College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala, India. Ms Garima had about 1.5 years of experience as an officer in the Quality control department at Zenacts Pharma Manimajra, Chandigarh. Her M.Pharmacy project focused on the topic of “Preparation and evaluation of Fusidic acid loaded transferosomes amalgamated with gel for the management of burn wound infection”. She has published more than 10 publications, including 1 Patent, and 5 book chapters. Her area of interest is nanotechnology, hydrogels, biomaterials, and their application in drug delivery. Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.Dr Meenakshi Dhanawat, is currently working as Associate Professor in Amity Institute of Pharmacy, Amity University Haryana. She has a background in Pharmaceutical Sciences with a specialization in Medicinal Chemistry. She has done Masters from NIPER, Mohali and the project was based on Glycosylamino acids. Her PhD is from IIT-BHU, Varanasi and she worked on CNS drug delivery targeting 5HT1A/2A receptor. Apart from that she has a vast experience in the extraction of herbal drugs. Area of interest are Synthetic Chemistry, Heterocyclic Chemistry, Nanotechnology, Drug Delivery, Prodrug and Co-Drug Drug Design Complexation, Polymer Chemistry, and their application in drug delivery.She has 17 years of teaching and research experience. She has attended several national and international conferences in india and abroad the recipient of the travelship award in DDD section of AAPS-2010, National Biotechnology Conference, California, USA. She has been able to grab the international travel grant from DBT and DST for attending the International Conference at California, USA and Munich, Germany Respectively. She has also grabbed many other fellowships awards, which includes Rajiv Gandhi National Fellowship. She has Published more than 85 Research/Reviews along with Patent-06, Books 6, Book Chapter 22, Book Editor 02, Copyright 01.

• 1. Understanding the Microbiome: Microbiome and Immune System Interactions2. The Microbiome: Its Impact on Cancer Development and Therapeutic Responses3. Microbiome Dynamics in Cancer Treatment: Impact of Chemotherapy on the Microbiome4. Microbiome as a Modulator of Immunotherapy: Synergistic Effects of the Microbiome in Immunotherapy5. Microbiome-Based Strategies to Overcome Chemoresistance: Probiotics and Prebiotics in Cancer Therapy6. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy7. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy8. Cancer pharmacomicrobiomics: targeting microbiota to optimize cancer therapy outcomes9. Gut microbiome in modulating immune checkpoint inhibitors10. Microbiome-based diagnostics and biomarkers: The search for mechanistic connections11. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors12. Current challenges and Future Prospects for Microbiome Research in Cancer Treatment